For neuromyelitis optica spectrum disorder, long-term follow-up with a second-generation complement inhibitor shows an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback